| Meriam Magtagad, PT | |
|
7904 Metropolitan Ave, Middle Village, NY 11379-2931 | |
| (718) 894-2323 | |
| (718) 894-5385 |
| Full Name | Meriam Magtagad |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 30 Years |
| Location | 7904 Metropolitan Ave, Middle Village, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144479452 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 025221 (New York) | Primary |
| Provider Name | Middle Village Chiropractic & Physical Therapy, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1962674572 PECOS PAC ID: 7618049495 Enrollment ID: O20080710000787 |
News Archive
GTx, Inc. today announced that a per protocol safety review of unblinded safety data on Friday April 12, 2013, by an independent Data Safety Monitoring Board, resulted in a determination that GTx continue as planned its two pivotal Phase III clinical trials of enobosarm (GTx-024) for the prevention and treatment of muscle wasting in patients with advanced non-small cell lung cancer.
The detonation of atomic bombs over the Japanese cities of Hiroshima and Nagasaki in August 1945 resulted in horrific casualties and devastation. The long-term effects of radiation exposure also increased cancer rates in the survivors.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of a global Phase 2b clinical trial evaluating aldoxorubicin compared to topotecan in subjects with extensive-stage small cell lung cancer (SCLC) who have relapsed or were refractory to prior chemotherapy.
Although there are recommendations for pregnant women to increase their intake of the omega-3 fatty acid docosahexaenoic acid (DHA) to improve fetal brain development, a randomized trial finds that prenatal DHA supplementation did not result in improved cognitive, problem-solving or language abilities for children at four years of age, according to the study in the May 7 issue of JAMA, a theme issue on child health.
› Verified 3 days ago
| Provider Name | Diaspo Chiropractic & Physical Therapy, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1487826004 PECOS PAC ID: 8729127964 Enrollment ID: O20091202000209 |
News Archive
GTx, Inc. today announced that a per protocol safety review of unblinded safety data on Friday April 12, 2013, by an independent Data Safety Monitoring Board, resulted in a determination that GTx continue as planned its two pivotal Phase III clinical trials of enobosarm (GTx-024) for the prevention and treatment of muscle wasting in patients with advanced non-small cell lung cancer.
The detonation of atomic bombs over the Japanese cities of Hiroshima and Nagasaki in August 1945 resulted in horrific casualties and devastation. The long-term effects of radiation exposure also increased cancer rates in the survivors.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of a global Phase 2b clinical trial evaluating aldoxorubicin compared to topotecan in subjects with extensive-stage small cell lung cancer (SCLC) who have relapsed or were refractory to prior chemotherapy.
Although there are recommendations for pregnant women to increase their intake of the omega-3 fatty acid docosahexaenoic acid (DHA) to improve fetal brain development, a randomized trial finds that prenatal DHA supplementation did not result in improved cognitive, problem-solving or language abilities for children at four years of age, according to the study in the May 7 issue of JAMA, a theme issue on child health.
› Verified 3 days ago
| Provider Name | Adam I Cohen Dpt Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1316247752 PECOS PAC ID: 9931382728 Enrollment ID: O20110401000273 |
News Archive
GTx, Inc. today announced that a per protocol safety review of unblinded safety data on Friday April 12, 2013, by an independent Data Safety Monitoring Board, resulted in a determination that GTx continue as planned its two pivotal Phase III clinical trials of enobosarm (GTx-024) for the prevention and treatment of muscle wasting in patients with advanced non-small cell lung cancer.
The detonation of atomic bombs over the Japanese cities of Hiroshima and Nagasaki in August 1945 resulted in horrific casualties and devastation. The long-term effects of radiation exposure also increased cancer rates in the survivors.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of a global Phase 2b clinical trial evaluating aldoxorubicin compared to topotecan in subjects with extensive-stage small cell lung cancer (SCLC) who have relapsed or were refractory to prior chemotherapy.
Although there are recommendations for pregnant women to increase their intake of the omega-3 fatty acid docosahexaenoic acid (DHA) to improve fetal brain development, a randomized trial finds that prenatal DHA supplementation did not result in improved cognitive, problem-solving or language abilities for children at four years of age, according to the study in the May 7 issue of JAMA, a theme issue on child health.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meriam Magtagad, PT 7904 Metropolitan Ave, Middle Village, NY 11379-2931 Ph: (718) 894-2323 | Meriam Magtagad, PT 7904 Metropolitan Ave, Middle Village, NY 11379-2931 Ph: (718) 894-2323 |
News Archive
GTx, Inc. today announced that a per protocol safety review of unblinded safety data on Friday April 12, 2013, by an independent Data Safety Monitoring Board, resulted in a determination that GTx continue as planned its two pivotal Phase III clinical trials of enobosarm (GTx-024) for the prevention and treatment of muscle wasting in patients with advanced non-small cell lung cancer.
The detonation of atomic bombs over the Japanese cities of Hiroshima and Nagasaki in August 1945 resulted in horrific casualties and devastation. The long-term effects of radiation exposure also increased cancer rates in the survivors.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of a global Phase 2b clinical trial evaluating aldoxorubicin compared to topotecan in subjects with extensive-stage small cell lung cancer (SCLC) who have relapsed or were refractory to prior chemotherapy.
Although there are recommendations for pregnant women to increase their intake of the omega-3 fatty acid docosahexaenoic acid (DHA) to improve fetal brain development, a randomized trial finds that prenatal DHA supplementation did not result in improved cognitive, problem-solving or language abilities for children at four years of age, according to the study in the May 7 issue of JAMA, a theme issue on child health.
› Verified 3 days ago
Kinga Tarczalowicz, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8451 64th Rd Apt 1, Middle Village, NY 11379 Phone: 718-909-0076 | |
Mrs. Lisa Bisbano, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7252 Metropolitan Ave, Middle Village, NY 11379 Phone: 718-326-0055 | |
Lech Biernacki, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6622 Gray St Apt 1, Middle Village, NY 11379 Phone: 917-515-1264 | |
Mr. Moustafa Abouelela, PHYSICAL THERAPY Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 6188 Dry Harbor Rd, 5e, Middle Village, NY 11379 Phone: 646-724-4459 Fax: 718-424-5070 | |
Dr. Tristan Zaide, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 8525 60th Rd Apt 2a, Middle Village, NY 11379 Phone: 516-476-4928 | |
J Moon Physical Therapy Pc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7945 Metropolitan Ave, Middle Village, NY 11379 Phone: 347-421-8173 |